VC  Transformation Capital

https://www.transformcap.com/





     Office Locations:

699 Boylston Street, 2nd Floor
Boston, MA 02116
Phone: 617-984-6355

 

Stages:

  • Expansion
  • Growth


 

Industries:

  • Life Sciences & Healthcare

  •  

    Description:

    Founded 2019, Transformation Capital is looking for innovative commercial-stage healthcare technology and services companies leading the transformation of the healthcare system. The firm targets companies providing software and related business services to serve any key healthcare stakeholders, including providers, payors, biopharmaceutical companies, employers, consumers and other vendors. In healthcare services, we invest in companies providing technology-enabled services to the industry stakeholders as well as novel models of direct patient care. Transformation Capital typically invests $10-30 million over the life of its involvement with a company. The firm invests in revenue-stage businesses with multiple referenceable customers, in companies with headquarters and senior management teams based in the continental United States.


     

    Funds:


      Fund Name


      Amount


      Date

    Get funds under management for this firm including Fund name, Dollar size of fund raise, and Vintage with a National Database subscription.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Akanksha Mehta Senior Associate
    Jared Kesselheim Co-founder & Managing Partner
    Julie Murchinson Partner
    Mike Dixon Managing Partner
    Todd Cozzens Co-founder & Managing Partner

     

    Recent Funding Events (trailing 12 months):


      Date


      Name


      State


      Amount


      Stage


      08/02/2022


      Annexus Health


      PA


      $33,000,000


      Series B


      03/01/2022


      Nayya


      NY


      $55,000,000


      Series C


     

    Portfolio companies include:


      Annexus Health
        web link


      Cleo


      Datavant


      DexCare
        web link


      H1
        web link


      LetsGetChecked
        web link


      Nayya
        web link


      Olive


      PatientPing
        web link


      PatientPop
        web link


      Protenus
        web link


      RapidSOS
        web link


      TMRW Life Sciences
        web link


      Vital
        web link


     

    Recent News: